Tumor necrosis factor alpha inhibition of hepatitis B virus replication involves disruption of capsid Integrity through activation of NF-kappaB.
about
Identification and characterization of avihepadnaviruses isolated from exotic anseriformes maintained in captivityHepatitis B virus morphogenesisGlucose-regulated protein 78 demonstrates antiviral effects but is more suitable for hepatocellular carcinoma prevention in hepatitis B.N-terminal and C-terminal cytosine deaminase domain of APOBEC3G inhibit hepatitis B virus replication.Interferon prevents formation of replication-competent hepatitis B virus RNA-containing nucleocapsids.A Practical Model Evaluating Antiviral Cytokines by Natural Killer Cells in Treatment Naïve Patients with Chronic Hepatitis B Virus Infection.Tumor necrosis factor-alpha induced by hepatitis B virus core mediating the immune response for hepatitis B viral clearance in mice modelInhibition of hepatitis B virus replication by APOBEC3G in vitro and in vivoTransforming growth factor-β1 suppresses hepatitis B virus replication by the reduction of hepatocyte nuclear factor-4α expression.Overexpression of tumor necrosis factor alpha by a recombinant rabies virus attenuates replication in neurons and prevents lethal infection in miceEntecavir combined with furin inhibitor simultaneously reduces hepatitis B virus replication and e antigen secretion.TGF-β and iron differently alter HBV replication in human hepatocytes through TGF-β/BMP signaling and cellular microRNA expression.Hepatitis B virus X protein upregulates mTOR signaling through IKKβ to increase cell proliferation and VEGF production in hepatocellular carcinomaHepatitis D virus infection, replication and cross-talk with the hepatitis B virus.HBx-induced NF-κB signaling in liver cells is potentially mediated by the ternary complex of HBx with p22-FLIP and NEMO.MicroRNA-130a can inhibit hepatitis B virus replication via targeting PGC1α and PPARγHepatitis B virus core protein sensitizes hepatocytes to tumor necrosis factor-induced apoptosis by suppression of the phosphorylation of mitogen-activated protein kinase kinase 7Association between TNFAIP3 nonsynonymous single-nucleotide polymorphism rs2230926 and chronic hepatitis B virus infection in a Chinese Han population.The inhibitory effect of the hepatitis B virus singly-spliced RNA-encoded p21.5 protein on HBV nucleocapsid formation.Inhibition of hepatitis B virus replication by cIAP2 involves accelerating the ubiquitin-proteasome-mediated destruction of polymerase.Dynamics of HBV cccDNA expression and transcription in different cell growth phaseInhibitory effect of Phyllanthus urinaria L. extract on the replication of lamivudine-resistant hepatitis B virus in vitro.Infection Profiles of Selected Aquabirnavirus Isolates in CHSE CellsThe level of viral antigen presented by hepatocytes influences CD8 T-cell function.Doxorubicin Activates Hepatitis B Virus Replication by Elevation of p21 (Waf1/Cip1) and C/EBPα Expression.Tumor necrosis factor activates a conserved innate antiviral response to hepatitis B virus that destabilizes nucleocapsids and reduces nuclear viral DNA.DNA-dependent activator of interferon-regulatory factors inhibits hepatitis B virus replicationInduction of antiviral cytidine deaminases does not explain the inhibition of hepatitis B virus replication by interferons.Signal transduction pathways that inhibit hepatitis B virus replication.MITA/STING and Its Alternative Splicing Isoform MRP Restrict Hepatitis B Virus Replication.Tumor necrosis factor-alpha blockage therapy impairs hepatitis B viral clearance and enhances T-cell exhaustion in a mouse modelHepatocyte nuclear factor 1α downregulates HBV gene expression and replication by activating the NF-κB signaling pathwayInhibition of different Lassa virus strains by alpha and gamma interferons and comparison with a less pathogenic arenavirus.Immunopathogenesis of hepatitis B virus infection.Therapeutic vaccination in chronic hepatitis B virus carriers.Role of human beta-defensin-2 during tumor necrosis factor-alpha/NF-kappaB-mediated innate antiviral response against human respiratory syncytial virusHepatitis B virus genome replication triggers toll-like receptor 3-dependent interferon responses in the absence of hepatitis B surface antigenSynthetic DNA immunogen encoding hepatitis B core antigen drives immune response in liverHepatitis B virus replication and release are independent of core lysine ubiquitinationHBV replication is significantly reduced by IL-6.
P2860
Q24556680-D1CD8E66-7E10-4A1A-82BA-39477015F884Q24563883-291B2F37-A73D-4E51-96BD-AE0D74605980Q33560483-ADDC135B-80AA-4272-BFE0-4BCE711D57C7Q33866902-CA2E9C2C-3705-4E28-893F-CE0A6F6EC57FQ33896072-2F54A2BD-177A-4E7A-BD3F-D076810F5680Q33919051-44C1F1EA-2A90-451D-B300-9F58DFA276D0Q33927761-408B1F88-A885-405C-AB2B-19E0ECC19F2EQ34017631-EB6850A0-8A57-4BFA-9196-6827F8DDB35BQ34140521-2C3FC9D6-0303-4FFB-89F1-23190E2DE101Q34228539-ADC6B370-7E18-4764-A9ED-60F83118B6DBQ34256771-230E24BE-6C77-4ABD-AB81-E3C0D54610FAQ34314364-92684ECA-4E2D-419F-AA9D-F4383632B037Q34359262-CE889B6C-6CA3-49F9-8440-431DD7F3C68EQ34404998-C2937D7E-520F-41EA-ACE3-CC96EAED4651Q34618294-E8184DC5-75AD-43EA-AA01-B262DA28E7FAQ35113567-9EE543D7-9585-4DB6-A410-B0F3E963C49DQ35115529-93C78618-1ACF-40C2-B006-85D8A62790CBQ35177856-C90E7A7A-9B33-497C-9E34-AB1EA6DE4E5EQ35191793-0E18FDC0-E543-4214-8E97-F3AC673B5EAAQ35362817-1C0C8996-8282-419B-8425-35878B2CA664Q35682975-A882E692-602C-40D8-B108-B894D667B7D6Q35721334-36CE405B-571E-4D7A-8C17-2BA1F3E3A45AQ35742855-AFE8D6A7-7473-45C4-998B-63C56C8390D4Q35784981-8D937BEF-9DFF-493A-91EB-AF26F1A980ABQ35801644-4DB50913-6C7B-40C0-8D09-F43CBFDABDE3Q35914476-DB3160AF-3515-4A70-B529-611317F5C790Q36031350-36A3963B-78A6-4E17-AE78-D4A00F4A58A5Q36099079-114BBF58-A1C2-415E-9055-71E10F0BC618Q36162240-379A00DF-9EC5-4FFC-93CC-801A6494173CQ36240450-20802268-E4BE-4B81-A204-FF6F32C558DCQ36302689-0B1AF80B-3E1E-46BB-94F2-069773CB9258Q36314644-F260A07C-CC59-4A23-95B1-CA71B25BC990Q36509774-34607AE4-DF86-4A18-8B0E-1D9A22A40F88Q36666336-9E28D8C7-71AF-45A8-973B-C669F0D30F2DQ36689035-D93716D6-0550-42DE-9490-F4C74E9B2721Q36825544-B4AF9D91-A166-4981-AEE8-56263E9AC6EEQ36845647-798194C6-3D45-4D5D-B674-558A59120630Q36871557-1A251B09-C8A3-46F3-AFD3-2724A57226AFQ37192164-020892DE-AAE2-4BE1-8D44-0C6F0C9E5E77Q37204748-C49399EB-70B8-46B2-A0A9-28381807CD1C
P2860
Tumor necrosis factor alpha inhibition of hepatitis B virus replication involves disruption of capsid Integrity through activation of NF-kappaB.
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Tumor necrosis factor alpha in ...... rough activation of NF-kappaB.
@ast
Tumor necrosis factor alpha in ...... rough activation of NF-kappaB.
@en
Tumor necrosis factor alpha in ...... rough activation of NF-kappaB.
@nl
type
label
Tumor necrosis factor alpha in ...... rough activation of NF-kappaB.
@ast
Tumor necrosis factor alpha in ...... rough activation of NF-kappaB.
@en
Tumor necrosis factor alpha in ...... rough activation of NF-kappaB.
@nl
prefLabel
Tumor necrosis factor alpha in ...... rough activation of NF-kappaB.
@ast
Tumor necrosis factor alpha in ...... rough activation of NF-kappaB.
@en
Tumor necrosis factor alpha in ...... rough activation of NF-kappaB.
@nl
P2093
P2860
P1433
P1476
Tumor necrosis factor alpha in ...... rough activation of NF-kappaB.
@en
P2093
Michael Biermer
Robert J Schneider
Robyn Puro
P2860
P304
P356
10.1128/JVI.77.7.4033-4042.2003
P407
P577
2003-04-01T00:00:00Z